NOV
55
3
TROW
62
6
PRU
60
-2
PNW
55
2
SWK
61
6
R
67
4
YUM
58
2
USB
68
2
UNM
63
-2
STZ
48
6
CVS
40
3
NOC
58
4
OMC
66
-3
AAL
57
3
IR
63
5
XOM
50
5
NKE
31
-5
ORCL
37
4
APD
50
5
MU
79
4
NOV
55
3
TROW
62
6
PRU
60
-2
PNW
55
2
SWK
61
6
R
67
4
YUM
58
2
USB
68
2
UNM
63
-2
STZ
48
6
CVS
40
3
NOC
58
4
OMC
66
-3
AAL
57
3
IR
63
5
XOM
50
5
NKE
31
-5
ORCL
37
4
APD
50
5
MU
79
4
Financhill
Back

iShares JPX-Nikkei 400 ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
47

JPXN
iShares JPX-Nikkei 400 ETF

Last Price:
$87.1400
Seasonality Move:
1.35%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Sell
47
iShares JPX-Nikkei 400 ETF (JPXN) is a Sell

Is iShares JPX-Nikkei 400 ETF a Buy, Sell or Hold?

  • The current iShares JPX-Nikkei 400 ETF [JPXN] share price is $86.1283. The Score for JPXN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • JPXN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPXN Stock Price Chart

What is iShares JPX-Nikkei 400 ETF's stock price today?

  • The iShares JPX-Nikkei 400 ETF share price today is $86.1283
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPXN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

JPXN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 43.78 Sell
Chaikin Money Flow: 2999 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.6767 - 88.5567) Sell
Bollinger Bands (100): (83.926 - 87.946) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

JPXN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.34 Sell
20-day SMA: 87.54 Sell
50-day SMA: 87.2 Sell
200-day SMA: 81.14 Buy
8-day EMA: 86.87 Sell
20-day EMA: 87.26 Sell
50-day EMA: 86.89 Sell
200-day EMA: 82.27 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

iShares JPX-Nikkei 400 ETF Earnings Growth & JPXN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

iShares JPX-Nikkei 400 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):